New paper on psychedelic use in Germany published in Scientific Reports

Interest in psychedelics is growing, but population-based data on their use remain scarce. In this paper, we used data from 11,299 adults in the nationwide ENHANCE study to estimate the use of psychedelics in Germany, distinguishing between microdosing and medium-to-high doses. Overall, 5.0% reported lifetime use and 0.7% reported use in the past six months, with medium-to-high dosing being more common than microdosing. Many users had used more than one substance: 58.7% of lifetime LSD users had also used psilocybin. Use was less likely among women and older people. Recent microdosing was less common in rural areas, and recent medium-to-high dosing was less common among people with higher incomes or living with a partner. Our findings provide limited evidence for widespread psychedelic use in Germany and point to varied patterns across groups that could inform policy.

Read the paper: https://www.nature.com/articles/s41598-025-03873-0